Total Payments
$2,498
2024 Payments
$713.24
Companies
13
Transactions
66
Medicare Patients
313
Medicare Billing
$58,588
Payment Breakdown by Category
Food & Beverage$2,498 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,498 | 66 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Alkermes, Inc. | $633.36 | 7 | $0 (2023) |
| Vanda Pharmaceuticals Inc. | $344.68 | 9 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $295.47 | 6 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $288.24 | 8 | $0 (2024) |
| ABBVIE INC. | $271.58 | 9 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $228.35 | 9 | $0 (2022) |
| Otsuka America Pharmaceutical, Inc. | $200.02 | 7 | $0 (2024) |
| ITI, Inc. | $56.48 | 2 | $0 (2023) |
| Supernus Pharmaceuticals, Inc. | $55.63 | 3 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $47.12 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $713.24 | 20 | Vanda Pharmaceuticals Inc. ($235.86) |
| 2023 | $494.54 | 16 | ABBVIE INC. ($201.68) |
| 2022 | $365.34 | 13 | Alkermes, Inc. ($136.57) |
| 2021 | $43.51 | 2 | Vanda Pharmaceuticals Inc. ($23.56) |
| 2020 | $41.24 | 2 | Janssen Pharmaceuticals, Inc ($22.65) |
| 2019 | $322.00 | 6 | Sunovion Pharmaceuticals Inc. ($159.52) |
| 2018 | $116.76 | 2 | Alkermes, Inc. ($105.36) |
| 2017 | $400.99 | 5 | Alkermes, Inc. ($249.09) |
All Payment Transactions
66 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/03/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $36.27 | General |
| Category: Neuroscience | ||||||
| 09/20/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $10.25 | General |
| Category: Neuropsychiatry | ||||||
| 08/07/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $19.22 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 06/20/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $21.69 | General |
| Category: PSYCHIATRY | ||||||
| 06/19/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $33.28 | General |
| Category: Neuropsychiatry | ||||||
| 06/13/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $122.08 | General |
| Category: Neuropsychiatry | ||||||
| 06/05/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $18.26 | General |
| Category: Neuroscience | ||||||
| 06/04/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.06 | General |
| Category: NEUROSCIENCE | ||||||
| 05/22/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $33.21 | General |
| Category: NEUROSCIENCE | ||||||
| 05/07/2024 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $39.18 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 05/03/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $17.10 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 05/01/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $26.34 | General |
| Category: Central Nervous System | ||||||
| 04/18/2024 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $37.00 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 03/11/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.63 | General |
| Category: NEUROSCIENCE | ||||||
| 03/06/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | Cash or cash equivalent | $124.99 | General |
| Category: SCHIZOPHRENIA | ||||||
| 02/29/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $24.52 | General |
| Category: PSYCHIATRY | ||||||
| 02/27/2024 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $34.69 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 02/22/2024 | Indivior Inc. | PERSERIS (Drug) | Food and Beverage | In-kind items and services | $27.03 | General |
| Category: BH | ||||||
| 01/11/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $30.66 | General |
| Category: Neuropsychiatry | ||||||
| 01/08/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $20.78 | General |
| Category: Neurology | ||||||
| 11/08/2023 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $18.34 | General |
| Category: PSYCHIATRY | ||||||
| 11/08/2023 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $1.16 | General |
| Category: PSYCHIATRY | ||||||
| 10/18/2023 | Otsuka America Pharmaceutical, Inc. | NUEDEXTA (Drug) | Food and Beverage | In-kind items and services | $4.28 | General |
| Category: NEUROLOGY | ||||||
| 09/27/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $22.68 | General |
| Category: NEUROSCIENCE | ||||||
| 09/12/2023 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $26.80 | General |
| Category: Neuropsychiatry | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 127 | 334 | $41,565 | $25,788 |
| 2022 | 4 | 122 | 283 | $37,795 | $20,499 |
| 2021 | 4 | 64 | 168 | $22,870 | $12,301 |
Total Patients
313
Total Services
785
Medicare Billing
$58,588
Procedure Codes
12
All Medicare Procedures & Services
12 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 23 | 157 | $18,840 | $10,379 | 55.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 71 | 136 | $13,600 | $10,303 | 75.8% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Facility | 2023 | 22 | 26 | $6,500 | $3,669 | 56.5% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 11 | 15 | $2,625 | $1,437 | 54.7% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 30 | 171 | $20,520 | $10,205 | 49.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 41 | 56 | $5,600 | $3,951 | 70.6% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Facility | 2022 | 23 | 25 | $6,250 | $3,624 | 58.0% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 28 | 31 | $5,425 | $2,718 | 50.1% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 21 | 124 | $14,880 | $7,571 | 50.9% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Facility | 2021 | 16 | 16 | $4,000 | $2,354 | 58.8% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 15 | 16 | $2,800 | $1,442 | 51.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 12 | 12 | $1,190 | $933.74 | 78.5% |
About Dr. Ralph Menezes, M.D
Dr. Ralph Menezes, M.D is a Psychiatry healthcare provider based in Forest Park, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/24/2006. The National Provider Identifier (NPI) number assigned to this provider is 1568417996.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ralph Menezes, M.D has received a total of $2,498 in payments from pharmaceutical and medical device companies, with $713.24 received in 2024. These payments were reported across 66 transactions from 13 companies. The most common payment nature is "Food and Beverage" ($2,498).
As a Medicare-enrolled provider, Menezes has provided services to 313 Medicare beneficiaries, totaling 785 services with total Medicare billing of $58,588. Data is available for 3 years (2021–2023), covering 12 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Location Forest Park, IL
- Active Since 05/24/2006
- Last Updated 07/08/2007
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1568417996
Products in Payments
- Aristada 441 mg (Drug) $354.45
- INGREZZA (Drug) $295.47
- VRAYLAR (Drug) $271.58
- LATUDA (Drug) $228.35
- LYBALVI (Drug) $165.03
- FANAPT (Drug) $149.40
- HETLIOZ (Drug) $146.68
- INVEGA SUSTENNA (Drug) $141.98
- REXULTI (Drug) $140.54
- INVEGA TRINZA (Drug) $123.61
- ARISTADA (Drug) $113.88
- ABILIFY MAINTENA (Drug) $76.89
- CAPLYTA (Drug) $56.48
- Fanapt (Drug) $48.60
- Qelbree (Drug) $36.32
- SECUADO (Drug) $27.97
- PERSERIS (Drug) $27.03
- Austedo XR (Drug) $26.34
- SPRAVATO (Drug) $22.65
- UZEDY (Drug) $20.78
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Forest Park
Aamir Safdar, M.d, M.D
Psychiatry — Payments: $1,007
Psychiatry $1,007
Indupreet Nagra, Md, MD
Psychiatry — Payments: $653.70
Psychiatry $653.70
Dr. Daniel Faisal, M.d, M.D
Psychiatry — Payments: $252.51
Psychiatry $252.51
Panom Phoungcherdchoo, M.d, M.D
Psychiatry — Payments: $60.75
Psychiatry $60.75
Dianella Dizon-Menezes, Md, MD
Psychiatry
Psychiatry
Rayyan Sami, Md, MD
Psychiatry
Psychiatry